Call for proposals to support innovative manufacturing technologies and processes in the Union for medicines production (HERA) - CP-g-24-12

0 Saves · 0 Shares · 0 Comments Discussion

Grant Name

Funder

EU4 Health Programme (EU4H)

European Commission

Deadline

2024-09-05

Grant Size

€17000000

Eligibility

Conditions

1. Admissibility conditions: described in section 5 of the call document

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System

2. Eligible countries: described in section 6 of of the call document

3. Other eligibility conditions: described in section 6 of the call document

4. Financial and operational capacity and exclusion: described in section 7 of the call document

5. Evaluation and award:

Award criteria, scoring and thresholds: described in section 9 of the call document

Submission and evaluation processes: described section 8 of the call document and the Online Manual

Indicative timeline for evaluation and grant agreement: described in section 4 of the call document

6. Legal and financial set-up of the grants: described in section 10 of the call document

Documents

Call documents:

Call document

Standard application form ([ToA])

Detailed budget table ([ToA])

EU4Health Programme General MGA v1.1

EU4Health Work Programme 2024

EU4Health Regulation 2021/522

EU Financial Regulation 2018/1046

Grant Number

EU4H-2024-PJ-01-3

Description

Objective:

This action aims at supporting improved manufacturing technologies and processes that allow for a more effective, less expensive, easier to scale up, more sustainable and cleaner production of medicines in the Union. Innovations developed under this action should be designed to enable rapid scale-up of Union pharmaceutical production in the context of a health emergency or to prevent critical shortages of critical medicines. This action supports the Union’s pharmaceutical industry to be better able to respond to public health needs in the context of health emergencies and critical medicines shortages.

It does so by enabling the development of tools that contribute to the improvement and optimisation of manufacturing of medicines, with the objective of reducing production costs (e.g., related to labour and energy consumption), and facilitating compliance with the Union’s environmental occupational and social requirements, as well as the Union’s current and future needs to scale-up pharmaceutical production. This action supports the policy priority to enhance crisis preparedness and response for future health emergencies in relation to medical countermeasures with an all-threats approach, as well as preventing critical shortages of critical medicines, especially those in a situation of technological vulnerability with regards to the EU market. It implements the EU4Health Programme’s general objective of improving the availability, accessibility and affordability of crisis-relevant products (Article 3, point (c) of Regulation (EU) 2021/522) through the specific objectives defined in Article 4, points (b) and (c), of Regulation (EU) 2021/522.

Scope:

This action covers activities aimed at developing support for or innovations targeting the manufacturing of APIs, their intermediates and/or excipients, namely by developing:

a) novel manufacturing processes and technologies, e.g., additive manufacturing, continuous manufacturing and flow chemistry, and biomanufacturing technologies; combined or not with activities covering:

b) novel industrial manufacturing and facility designs, e.g., modular manufacturing, smart manufacturing execution systems, including automation and robotics, advanced analytics, and smart sensors, among other.

Overall, the action should contribute to increasingly sophisticated enhancements to chemical and/or biological processes or decreasing the production of polluting agents. This action is limited to manufacturing technologies and processes and does not cover innovation exclusively targeting the field of quality control.

Expected Impact:

This action is expected to result in:

a) more agile, simplified scale-up, sustainable and resilient manufacturing of APIs, their intermediates, finished products and/or excipients, allowing for better capacity to respond to demand surges and prevent critical shortages of critical medicines.

b) improved competitiveness of the Union’s manufacturing industry, improved Union’s strategic autonomy and more resilient Union’s industry in the field of medical countermeasures/medicines.

Funding resources
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link

Quick share

Add deadline to calendar

2024-09-05

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.

Suggest reading

Canadian Institutes of Health Research Profile

Bill and Melinda Gates Foundation Profile

Empowering Innovation: A Spotlight on the National Science Foundation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Related opportunities

DoD Breast Cancer, Breakthrough Award: Science and Technology and other Researc... Aug 06, 2024 12:00:00 AM EDT 13950000

DOD Spinal Cord Injury Research Program Translational Research Award: Science and Technology and other Researc... Aug 30, 2024 12:00:00 AM EDT 10320000

DoD Prostate Cancer, Physician Research Award: Science and Technology and other Researc... Aug 30, 2024 12:00:00 AM EDT 4800000

DoD Peer Reviewed Orthopaedic, Women's Health Research Award: Science and Technology and other Researc... Sep 17, 2024 12:00:00 AM EDT 3000000

DoD Peer Reviewed Cancer, Impact Award: Science and Technology and other Researc... Sep 26, 2024 12:00:00 AM EDT 16000000

DOD Pancreatic Cancer, Focused Pilot Award: Science and Technology and other Researc... Oct 03, 2024 12:00:00 AM EDT 1280000

DoD VRP, Clinical Trial Award: Science and Technology and other Researc... Nov 08, 2024 12:00:00 AM EST 2560000

Tribal Behavioral Health: Health May 15, 2025 12:00:00 AM EDT $250,000

Cancer Patient Care Program: Cancer 1-Aug-2025 $16,500,000.00

Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed): Health Sep 05, 2025 12:00:00 AM EDT 295924

Funding resources